Coric Vlad
Insider CIK 1704317 · RVNC Director · BHVN Chief Executive Officer, Director · RPRX Director · MANE Director · BHVN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma plc | A Award | 2026-06-05 | 2026-06-08 | 4,545 | — | $0 | 15,343 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2026-02-27 | 2026-03-03 | 550,000 | — | $0 | 550,000 | SEC↗ |
| MANE Veradermics, Inc | C Conversion deriv | 2026-02-05 | 2026-02-05 | 78,075 | — | $0 | 0 | SEC↗ |
| MANE Veradermics, Inc | C Conversion deriv | 2026-02-05 | 2026-02-05 | 33,706 | — | $0 | 0 | SEC↗ |
| MANE Veradermics, Inc | C Conversion deriv | 2026-02-05 | 2026-02-05 | 33,706 | — | $0 | 0 | SEC↗ |
| MANE Veradermics, Inc | C Conversion deriv | 2026-02-05 | 2026-02-05 | 148,794 | — | $0 | 0 | SEC↗ |
| MANE Veradermics, Inc | C Conversion deriv | 2026-02-05 | 2026-02-05 | 148,794 | — | $0 | 0 | SEC↗ |
| MANE Veradermics, Inc | C Conversion deriv | 2026-02-05 | 2026-02-05 | 78,075 | — | $0 | 0 | SEC↗ |
| MANE Veradermics, Inc | C Conversion deriv | 2026-02-05 | 2026-02-05 | 117,112 | — | $0 | 0 | SEC↗ |
| MANE Veradermics, Inc | P Buy | 2026-02-05 | 2026-02-05 | 58,823 | $17.00 | $1000.0K | 319,398 | SEC↗ |
| MANE Veradermics, Inc | C Conversion | 2026-02-05 | 2026-02-05 | 117,112 | — | $0 | 129,939 | SEC↗ |
| MANE Veradermics, Inc | C Conversion | 2026-02-05 | 2026-02-05 | 78,075 | — | $0 | 260,575 | SEC↗ |
| MANE Veradermics, Inc | C Conversion | 2026-02-05 | 2026-02-05 | 78,075 | — | $0 | 260,575 | SEC↗ |
| MANE Veradermics, Inc | P Buy | 2026-02-05 | 2026-02-05 | 58,823 | $17.00 | $1000.0K | 319,398 | SEC↗ |
| MANE Veradermics, Inc | C Conversion | 2026-02-05 | 2026-02-05 | 148,794 | — | $0 | 182,500 | SEC↗ |
| MANE Veradermics, Inc | C Conversion | 2026-02-05 | 2026-02-05 | 33,706 | — | $0 | 33,706 | SEC↗ |
| MANE Veradermics, Inc | C Conversion | 2026-02-05 | 2026-02-05 | 33,706 | — | $0 | 33,706 | SEC↗ |
| MANE Veradermics, Inc | C Conversion | 2026-02-05 | 2026-02-05 | 148,794 | — | $0 | 182,500 | SEC↗ |
| MANE Veradermics, Inc | A Award deriv | 2026-02-03 | 2026-02-05 | 51,525 | — | $0 | 51,525 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2026-01-05 | 2026-01-07 | 14,250 | — | $0 | 28,500 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2026-01-05 | 2026-01-07 | 14,250 | — | $0 | 1,811,398 | SEC↗ |
| BHVN Biohaven Ltd. | F Tax w/h | 2026-01-05 | 2026-01-07 | 7,430 | $9.93 | $73.8K | 1,803,968 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2025-11-13 | 2025-11-17 | 333,333 | $7.50 | $2.50M | 1,195,275 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2025-11-13 | 2025-11-17 | 333,333 | $7.50 | $2.50M | 740,546 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-05-13 | 2025-05-14 | 7,614 | — | $0 | 10,798 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-04-21 | 2025-04-21 | 3,184 | — | $0 | 3,184 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 15,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 5,784 | $3.65 | $21.1K | 15,000 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2025-01-05 | 2025-01-07 | 14,250 | — | $0 | 42,750 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2025-01-05 | 2025-01-07 | 57,000 | — | $0 | 57,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2025-01-05 | 2025-01-07 | 343,000 | — | $0 | 343,000 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2025-01-05 | 2025-01-07 | 14,250 | — | $0 | 1,803,409 | SEC↗ |
| BHVN Biohaven Ltd. | F Tax w/h | 2025-01-05 | 2025-01-07 | 6,805 | $38.64 | $262.9K | 1,796,604 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2024-10-02 | 2024-10-03 | 21,052 | $47.50 | $1000.0K | 861,942 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2024-05-01 | 2024-05-03 | 23,458 | — | $0 | 23,458 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-05-01 | 2024-05-03 | 15,000 | — | $0 | 20,784 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2024-04-22 | 2024-04-23 | 121,951 | $41.00 | $5.00M | 1,788,417 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-04-05 | 2024-04-05 | 231 | — | $0 | 840,890 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-04-05 | 2024-04-05 | 232 | — | $0 | 1,666,466 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-04-05 | 2024-04-05 | 231 | — | $0 | 407,213 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-03-08 | 2024-03-08 | 2,155 | — | $0 | 840,659 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-03-08 | 2024-03-08 | 2,155 | — | $0 | 406,982 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-03-08 | 2024-03-08 | 2,162 | — | $0 | 1,666,234 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-01-08 | 2024-01-10 | 5,384 | — | $0 | 404,827 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-01-08 | 2024-01-10 | 5,384 | — | $0 | 838,504 | SEC↗ |
| BHVN Biohaven Ltd. | A Award | 2024-01-08 | 2024-01-10 | 5,400 | — | $0 | 1,662,431 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2024-01-02 | 2024-01-04 | 275,000 | — | $0 | 275,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2023-11-02 | 2023-11-06 | 225,000 | — | $0 | 225,000 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2023-10-05 | 2023-10-10 | 113,637 | $22.00 | $2.50M | 1,657,031 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2023-10-05 | 2023-10-10 | 340,908 | $22.00 | $7.50M | 833,120 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-05-03 | 2023-05-05 | 986 | — | $0 | 986 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-05-03 | 2023-05-05 | 589 | — | $0 | 5,784 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 8,576 | — | $0 | 8,576 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-03 | 5,195 | — | $0 | 5,195 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-31 | 2022-11-01 | 25,800 | $15.97 | $412.0K | 1,543,394 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-28 | 2022-10-31 | 100,000 | $14.82 | $1.48M | 109,565 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-28 | 2022-10-31 | 41,930 | $14.87 | $623.5K | 1,517,594 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-25 | 2022-10-26 | 853,380 | $10.50 | $8.96M | 1,475,664 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 2,100 | $12.35 | $25.9K | 399,443 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 54,329 | $11.83 | $642.7K | 492,212 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 73,331 | $8.82 | $646.8K | 322,461 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 73,005 | $8.82 | $643.9K | 229,755 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 34,515 | $9.90 | $341.7K | 356,976 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 52,523 | $11.79 | $619.2K | 397,343 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 80,606 | $10.82 | $872.2K | 344,820 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 80,907 | $10.83 | $876.2K | 437,883 | SEC↗ |
| BHVN Biohaven Ltd. | P Buy | 2022-10-05 | 2022-10-06 | 34,459 | $9.89 | $340.8K | 264,214 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 196,916 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 250,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 75,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 100,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 50,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 40,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 180,760 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 19,240 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 3,084 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 87,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 97,602 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,398 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 69,225 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 775 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 10,950 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 25,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 30,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 4,444 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 4,444 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 4,444 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 13,336 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 13,336 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 37,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 50,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 25,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 20,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 90,380 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 9,620 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 1,542 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 98,458 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 43,750 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 48,801 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 1,199 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 34,612 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 387 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 37,500 | — | $0 | 37,500 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 90,380 | — | $0 | 90,380 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 387 | — | $0 | 387 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 9,620 | — | $0 | 9,620 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 1,542 | — | $0 | 1,542 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 98,458 | — | $0 | 98,458 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 43,750 | — | $0 | 43,750 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 48,801 | — | $0 | 48,801 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 1,199 | — | $0 | 1,199 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 34,612 | — | $0 | 34,612 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 125,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2022-10-03 | 2022-10-05 | 950,000 | — | $0 | 950,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 498,261 | $148.50 | $73.99M | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 19,130 | $148.50 | $2.84M | 498,261 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 313,500 | $148.50 | $46.55M | 517,391 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 92,050 | $148.50 | $13.67M | 830,891 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 43,750 | $2.84 | $124.3K | 696,169 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 48,801 | $4.13 | $201.5K | 652,419 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 1,199 | $4.13 | $5.0K | 603,618 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 34,612 | $6.37 | $220.5K | 602,419 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 387 | $6.37 | $2.5K | 567,807 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 5,475 | — | $0 | 567,420 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 12,500 | — | $0 | 561,945 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 15,000 | — | $0 | 549,445 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 2,222 | — | $0 | 534,445 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 2,222 | — | $0 | 532,223 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 2,222 | — | $0 | 530,001 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 6,666 | — | $0 | 527,779 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 6,668 | — | $0 | 521,113 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 52,975 | — | $0 | 514,445 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 461,470 | — | $0 | 461,470 | SEC↗ |
| BHVN Biohaven Ltd. | F Tax w/h | 2022-10-03 | 2022-10-05 | 115,940 | $7.50 | $869.5K | 1,037,729 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 125,000 | $0.04 | $5.0K | 1,153,669 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 37,500 | $0.28 | $10.5K | 1,028,669 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 50,000 | $0.28 | $14.0K | 991,169 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 25,000 | $0.46 | $11.5K | 941,169 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 20,000 | $0.54 | $10.8K | 916,169 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 90,380 | $1.03 | $93.1K | 896,169 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 9,620 | $1.03 | $9.9K | 805,789 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 98,458 | $1.61 | $158.5K | 794,627 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 1,542 | $1.61 | $2.5K | 796,169 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 9,565 | — | $0 | 9,565 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 156,750 | — | $0 | 156,750 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 46,025 | — | $0 | 622,284 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 249,130 | — | $0 | 249,130 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-12 | 0 | — | $0 | 569,309 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-07 | 2022-01-07 | 10,000 | — | $0 | 30,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-07 | 2022-01-07 | 4,634 | $128.87 | $597.2K | 37,584 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-07 | 2022-01-07 | 10,000 | — | $0 | 42,218 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-06 | 2022-01-07 | 12,500 | — | $0 | 25,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-06 | 2022-01-07 | 12,500 | — | $0 | 38,072 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-06 | 2022-01-07 | 5,854 | $123.86 | $725.1K | 32,218 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-11-25 | 2021-11-26 | 10,950 | — | $0 | 10,950 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-11-25 | 2021-11-26 | 10,950 | — | $0 | 30,359 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2021-11-25 | 2021-11-26 | 5,075 | $115.55 | $586.4K | 25,284 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-01-06 | 2021-01-08 | 12,500 | — | $0 | 37,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-01-06 | 2021-01-08 | 12,500 | — | $0 | 25,211 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2021-01-06 | 2021-01-08 | 5,802 | $83.38 | $483.8K | 19,409 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-11-25 | 2020-11-27 | 10,950 | — | $0 | 21,900 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2020-11-25 | 2020-11-27 | 4,965 | $90.14 | $447.5K | 11,970 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-11-25 | 2020-11-27 | 10,950 | — | $0 | 16,935 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | G Gift | 2019-12-31 | 2019-12-31 | 100,000 | — | $0 | 340,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | G Gift | 2019-12-31 | 2019-12-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | G Gift | 2019-12-31 | 2019-12-31 | 100,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | G Gift | 2019-12-31 | 2019-12-31 | 100,000 | — | $0 | 105,985 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-12-18 | 2019-12-20 | 10,950 | — | $0 | 32,850 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2019-12-18 | 2019-12-20 | 4,965 | $52.13 | $258.8K | 5,985 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-12-18 | 2019-12-20 | 10,950 | — | $0 | 10,950 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-11-25 | 2019-11-27 | 43,800 | — | $0 | 43,800 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-11-25 | 2019-11-27 | 87,500 | — | $0 | 87,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | P Buy | 2019-06-26 | 2019-06-26 | 5,000 | $40.22 | $201.1K | 19,130 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-03-14 | 2019-03-14 | 15,783 | $50.03 | $789.6K | 440,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-03-14 | 2019-03-14 | 16,110 | $50.02 | $805.8K | 475,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-03-13 | 2019-03-14 | 8,262 | $50.02 | $413.3K | 455,783 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-03-13 | 2019-03-14 | 7,883 | $50.02 | $394.3K | 491,110 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-03-12 | 2019-03-14 | 26,007 | $50.15 | $1.30M | 498,993 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-03-12 | 2019-03-14 | 25,955 | $50.15 | $1.30M | 464,045 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2018-06-01 | 2018-06-01 | 5,229 | $35.04 | $183.2K | 525,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2018-06-01 | 2018-06-01 | 8,611 | $35.04 | $301.7K | 525,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2018-05-31 | 2018-06-01 | 18,971 | $35.01 | $664.2K | 530,229 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2018-05-31 | 2018-06-01 | 15,648 | $35.01 | $547.8K | 533,611 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2018-05-30 | 2018-06-01 | 800 | $35.00 | $28.0K | 549,200 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2018-05-30 | 2018-06-01 | 741 | $35.00 | $25.9K | 549,259 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-12-07 | 2017-12-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-11-01 | 2017-11-02 | 6,926 | $29.62 | $205.1K | 575,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-11-01 | 2017-11-02 | 18,074 | $29.10 | $526.0K | 581,926 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-11-01 | 2017-11-02 | 6,926 | $29.62 | $205.1K | 575,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-11-01 | 2017-11-02 | 18,074 | $29.10 | $526.0K | 581,926 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-10-31 | 2017-11-02 | 1,050 | $30.51 | $32.0K | 600,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-10-31 | 2017-11-02 | 23,122 | $29.96 | $692.7K | 601,050 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-10-31 | 2017-11-02 | 25,828 | $29.04 | $750.0K | 624,172 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-10-31 | 2017-11-02 | 25,827 | $29.04 | $750.0K | 624,173 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-10-31 | 2017-11-02 | 23,123 | $29.96 | $692.8K | 601,050 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2017-10-31 | 2017-11-02 | 1,050 | $30.51 | $32.0K | 600,000 | SEC↗ |